Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Pediatr Gastroenterol Nutr ; 64(2): 292-295, 2017 02.
Article in English | MEDLINE | ID: mdl-28114244

ABSTRACT

OBJECTIVES: Patients with cystic fibrosis (CF) and pancreatic insufficiency are prescribed fat-soluble vitamins, although compliance remains low. Our objective was to identify patient and caregiver knowledge deficits regarding vitamin supplementation, provide targeted education, and examine serum vitamin levels pre-and posteducation. METHODS: This prospective quality improvement study involved 118 patients. A vitamin knowledge survey was given to patients/caregivers during a clinic visit, education was provided targeting knowledge deficits, and the survey was re-administered at the next clinic visit. Serum vitamin levels were collected at pre- and postsurvey. RESULTS: Results showed significant pre-post increases for patient and caregiver knowledge scores, and significant decreases in self-reported nonadherence to vitamin use and number of reported barriers affecting adherence. A significant change in vitamin E level to therapeutic range post-education was demonstrated. CONCLUSIONS: Our brief, targeted educational interventions regarding vitamin supplementation showed utility in a routine clinic setting.


Subject(s)
Cystic Fibrosis/drug therapy , Dietary Supplements , Health Knowledge, Attitudes, Practice , Medication Adherence/statistics & numerical data , Patient Education as Topic , Quality Improvement , Vitamins/therapeutic use , Adolescent , Adult , Aged , Biomarkers/blood , Child , Child, Preschool , Cystic Fibrosis/blood , Female , Follow-Up Studies , Humans , Infant , Male , Middle Aged , Prospective Studies , Self Report , Vitamins/blood , Young Adult
2.
Antimicrob Agents Chemother ; 60(10): 6252-9, 2016 10.
Article in English | MEDLINE | ID: mdl-27503642

ABSTRACT

This study aimed to investigate the pharmacokinetics (PK), safety, and tolerability of a single dose of ceftazidime-avibactam in pediatric patients. A phase I, multicenter, open-label PK study was conducted in pediatric patients hospitalized with an infection and receiving systemic antibiotic therapy. Patients were enrolled into four age cohorts (cohort 1, ≥12 to <18 years; cohort 2, ≥6 to <12 years; cohort 3, ≥2 to <6 years; cohort 4, ≥3 months to <2 years). Patients received a single 2-h intravenous infusion of ceftazidime-avibactam (cohort 1, 2,000 to 500 mg; cohort 2, 2,000 to 500 mg [≥40 kg] or 50 to 12.5 mg/kg [<40 kg]; cohorts 3 and 4, 50 to 12.5 mg/kg). Blood samples were collected to describe individual PK characteristics for ceftazidime and avibactam. Population PK modeling was used to describe characteristics of ceftazidime and avibactam PK across all age groups. Safety and tolerability were assessed. Thirty-two patients received study drug. Mean plasma concentration-time curves, geometric mean maximum concentration (Cmax), and area under the concentration-time curve from time zero to infinity (AUC0-∞) were similar across all cohorts for both drugs. Six patients (18.8%) reported an adverse event, all mild or moderate in intensity. No deaths or serious adverse events occurred. The single-dose PK of ceftazidime and avibactam were comparable between each of the 4 age cohorts investigated and were broadly similar to those previously observed in adults. No new safety concerns were identified. (This study has been registered at ClinicalTrials.gov under registration no. NCT01893346.).


Subject(s)
Azabicyclo Compounds/administration & dosage , Azabicyclo Compounds/pharmacokinetics , Ceftazidime/administration & dosage , Ceftazidime/pharmacokinetics , beta-Lactamase Inhibitors/administration & dosage , beta-Lactamase Inhibitors/pharmacokinetics , Adolescent , Azabicyclo Compounds/adverse effects , Ceftazidime/adverse effects , Child , Child, Preschool , Drug Combinations , Female , Hospitals, Pediatric , Humans , Infant , Male
4.
J Dent Educ ; 88(1): 5-15, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37740558

ABSTRACT

PURPOSE: To improve health equity, dental and medical students must have a firm grasp of the proper use of race as a social construct. The purpose of this study was to determine the degree to which an innovative learning event affected students' understanding of race as a social construct. It also sought to examine the effects that personally experienced and/or witnessed racism and previous education had on students' responses to the learning event. METHODS: In 2022, all incoming first-year dental (N = 48) and medical (N = 114) students completed an online pre-matriculation assignment about the use of race in healthcare. Students initially completed an anonymous 14-item pre-survey and then read assigned publications, followed by answering questions about a real-life vignette concerning the topic of race as a social construct. Students finished the assignment by completing an anonymous seven-item post-survey. Data from the pre- and post-surveys were collected and analyzed to assess if differences existed among students and between the two surveys. RESULTS: Dental and medical students were significantly more likely to endorse race as a social construct after the learning experience (p < 0.001). Students who had experienced discrimination or obtained training were more likely to define race as a social construct before and after the learning event. CONCLUSION: Dental and medical schools can increase students' understanding of race as a social construct, rather than a biological construct, with educational interventions.


Subject(s)
Racism , Students, Medical , Humans , Students, Dental , Learning , Surveys and Questionnaires
6.
J Pediatric Infect Dis Soc ; 5(3): e21-3, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27021037

ABSTRACT

Although congenital herpes simplex virus (HSV) infection is rare, it is associated with severe morbidity. We report a 36-week gestational age infant who presented with atypical skin lesions, presumably mitigated by exposure to maternal antiviral suppressive therapy. The initial absence of typical herpetic vesicles and lack of viral detection in skin lesions delayed the correct diagnosis, highlighting the importance of differentiating HSV from other neonatal rashes.


Subject(s)
Herpes Simplex/congenital , Pregnancy Complications, Infectious , Female , Herpes Simplex/diagnosis , Humans , Infant, Newborn , Pregnancy , Simplexvirus
8.
Oral Maxillofac Surg Clin North Am ; 24(3): 469-86, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22739434

ABSTRACT

Infections in children in the head and neck regions are common, leading to frequent use and overuse of antibiotics. This review includes common as well as diverse and unusual infectious diseases, such as PFAPA (Periodic Fever Aphthous stomatitis, Pharyngitis, Adenitis) syndrome, Lemierre Syndrome, Arcanobacterium infection, and tuberculous and nontuberculous adenitis, which occur in infants, children, and adolescents. In addition, the first pediatric vaccines available with the potential to prevent oropharyngeal cancers are reviewed.


Subject(s)
Lymphadenitis/diagnosis , Lymphadenitis/therapy , Orbital Cellulitis/diagnosis , Orbital Cellulitis/therapy , Oropharyngeal Neoplasms/virology , Otitis Media/diagnosis , Otitis Media/therapy , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/therapy , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/therapy , Adolescent , Child , Child, Preschool , Diagnosis, Differential , Diagnostic Imaging , Fever/diagnosis , Fever/therapy , Humans , Infant , Lymphadenitis/microbiology , Orbital Cellulitis/microbiology , Oropharyngeal Neoplasms/diagnosis , Oropharyngeal Neoplasms/therapy , Otitis Media/microbiology , Pharyngitis/diagnosis , Pharyngitis/microbiology , Pharyngitis/therapy , Sinusitis/diagnosis , Sinusitis/microbiology , Sinusitis/therapy , Stomatitis, Aphthous/microbiology , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL